Poster presentations II

Session detail

PA-021
Tracking pneumococcal serotype replacement in carriage and invasive disease in The Gambia 
Baleng Mahama Wutor, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, The Gambia

PA-076
Global south and global north partnership to strengthen operational research capacities for health systems improvement in Sierra Leone 
Ibrahim Franklyn Kamara, World Health Organization, Sierra Leone

PA-045
Seroprevalence of HBV, HCV, and HIV 1 and 2 among Female Sex Workers and Female Non-sex Workers in Osun State, Nigeria 
Oluyinka Oladele Opaleye, Ladoke Akintola University of Technology, Nigeria

PA-150
Risk-based screening and prioritization of clinical trial research ethics applications using LLMs
Japie van Tonder, Scigenix Pty Ltd, South Africa

PA-157
An innovative online clinical trial operations training program for Africa (ClinOps)
Dawit Ejigu, CDT-Africa, Ethiopia

PA-158
Group antenatal care model improved uptake of eight-contact antenatal care in primary health care facilities in northwest Ethiopia: A cluster randomized controlled trial
Muhabaw Shumye Mihret, University of Gondar, Ethiopia

PA-165
Integrating micronutrient surveillance into a public health reference laboratory: a pilot study in Uganda 
Hellen Nansumba, National Health Laboratory Services (NHLDS), Uganda

PA-196
Sickle cell disease among Plasmodium falciparum infected individuals in the Ashanti Region of Ghana 
Paulina Otu, Wisconsin International University College, Ghana

PA-203
Postnatal cytomegalovirus infection and its effect on hearing and neurodevelopmental outcomes among infants aged 3 – 10 months: A cohort study in Eastern Uganda
Noela Regina Akwi Okalany, University of Bergen, Uganda

PA-211
Genetic regulators of plasma protein expression in Tanzanian population with comparison to the European population 
Caroline Amour, Kilimanjaro Christian Medical University College (KCMUCO), Tanzania

PA-212
Background rates of adverse events for vaccine safety monitoring at two sentinel hospitals in Addis Ababa, Ethiopia 
Kassech Sintayehu, Ohio State Global One Health, LLC, Ethiopia

PA-222
Mpox knowledge, affiliation, and willingness to accept mpox vaccine among people living with HIV and men who have sex with men in Rivers State, Nigeria 
Chizaram Onyeaghala, University of Port Harcourt Teaching Hospital, Nigeria

PA-237
Strengthening the quality of ethical review in low- and middle-income countries: the case of Ethiopia 
Hailemichael Getachew, Armauer Hansen Research Institute, Ethiopia

PA-250
Progress of the EU-Africa HOLICARE project: advancing respiratory disease diagnostics through collaborative research 
Aman Russom, KTH Kungliga Tekniska Högskolan, Sweden

PA-256
Bridging evidence gaps to advance infant/child vaccination against mpox in the DRC: phase 3 trial of the MVA-BN Vaccine
Solange Milolo Tshilumba, Université de Kinshasa, Département de Médecine Tropicale, Democratic Republic of the Congo

PA-262
Spatio-temporal trend of ACT efficacy over ten years from 2010 to 2024 in sub-Saharan Africa: a systematic review and meta-analysis
Francis Bohissou, Institut of Tropical Medicine, Tübingen, Germany

PA-264
Setting up contract research organizations in sub-Saharan Africa: a qualitative study of challenges, opportunities, and prospects 
Shiferaw Tilahun, Ethiopian Public Health Institute, Ethiopia

PA-284
Cartoon–video-based versus standard paper-based consent administration methods to enhance understanding of study information in resource-limited settings: a randomized trial 
Boris K Tchounga, Elizabeth Glaser Pediatric AIDS Foundation, Cameroon

PA-300
Understanding vaccination hesitancy and evaluating single dose and gender-neutral vaccination strategies to improve HPV vaccine uptake in West and East Africa: The IMPROVE-HPV Project 
John Changalucha, Mwanza Intervention Trials Unit, National Institute for Medical Research, Tanzania

PA-309
Plasmo3Net: A Convolutional Neural Network-Based Algorithm for Detecting Malaria Parasites in Thin Blood Smear Images
Funmilayo Ligali, Centre for Genomic Research in Biomedicine, Nigeria

PA-310
MESH’s interactive online training course on Community Engagement and Involvement with Global Health Research 
Shekha Mohamed, Ifakara Health Institute, Tanzania

PA-318
Community-based delivery of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy in Kenya: the role of community health promoters 
Zoe Nakuya, Population Council, Kenya

PA-327
Determinants of overweight and obesity among women of reproductive age in Cabo Verde, between 2018-2023 
Ricardo Luz, Faculdade de Ciências e Tecnologia, Universidade de Cabo Verde, Cape Verde

PA-352
NLRP3 inflammasome-targeted Ascorbyl Stearate/Polyethyleneimine Lipid-Dendrimer Hybrid Nanosystem loaded with Vancomycin for MRSA-induced Sepsis
Eman Abdallah Ismail Abdallah, University of KwaZulu-Natal, South Africa

PA-378
Prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine: a multi-country evaluation after two years of perennial malaria chemoprevention implementation as part of the Multiply project 
Essoham Ataba, National Malaria Control Program, Togo

PA-383
What is the journey of parents of children suffering from severe malaria, from low-level h facilities to higher-level facilities, in the Kapolowe health zone?
Deborah Bora Kanyamukenge, Lubumbashi University, Democratic Republic of the Congo

PA-404
Understanding caregivers’ perspectives on HPV vaccination: findings from a mixed-methods study in selected districts of Northern Sierra Leone 
Cristina Raya, Fundación Privada Instituto de Salud Global de Barcelona (ISGlobal), Spain

PA-430
Improvement in tablet taking after an adherence intervention: data from the RETAIN study
Catherine Orrell, Desmond Tutu HIV Centre, South Africa

PA-443
Strengthening capacity for regulators and researchers for clinical trials using gene therapy 
Helen Byomire Ndagije, National Drug Authority, Uganda

PA-451
Getting your words across: user experiences of qualitative evidence included in GRADE Evidence-to-Decision frameworks in the Global Evidence, Local Adaptation (GELA) project
Elodie Besnier, NTNU, Norway

PA-474
Exploring barriers and enablers to PMTCT and immunization retention across public health facilities in Zambia: a qualitative study 
Mwiya Mwiya, University Teaching Hospital, Zambia

PA-498
Integrating perennial malaria chemoprevention (PMC) into the expanded program on immunization in southeastern Mozambique: perceptions of acceptability, feasibility, and sustainability among local stakeholders 
Herminio Cossa, Centro de Investigacao em Saude de Manhica, Mozambique

PA-515
Neutrophil levels and artemisinin-based combination therapy efficacy in the treatment of Plasmodium falciparum infections in pregnant women and children 
Moussa Djimde, Malaria Research and Training Center, Mali

PA-529
Can metformin prevent or delay the onset of diabetes among people living with HIV and pre-diabetes: a phase III randomised placebo-controlled trial
Magreth Angelus, Shree Hindu Mandal Research and Training, Tanzania

PA-560
Bridging the Implementation Gap for Point-of-Care Diagnostic Tests for Acute Febrile Illness: A Qualitative Study in The Gambia, West Africa 
Mamadu Baldeh, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Gambia

PA-561
Evolution of Plasmodium falciparum resistance to antifolate antimalarial drugs in Uganda 
Victor Asua, IDRC, Uganda

PA-567
Research landscape and ethics capacities in Benin: the case of projects evaluated by CER-ISBA 
Kedote Marius, Comité d’éthique de la recherche de l’Institut des sciences biomédicales appliquées, Benin

PA-571
Undiagnosed diabetes among people living with HIV: a large cohort in Tanzania
Sokoine Kivuyo, NIMR-Muhimbili Centre, Tanzania

PA-589
Pharmacokinetics and pharmacodynamics of ganciclovir in infants living with HIV receiving valganciclovir for empirical treatment of CMV pneumonia in sub-Saharan Africa
Vivian Mumbiro, University of Zimbabwe Clinical Research Centre, Zimbabwe

PA-591
(Rapid) Genomic Surveillance of Measles Virus infections in Asella, Ethiopia, using the Oxford Nanopore Technology 
Anna Rommerskirchen, Heinrich-Heine-University Düsseldorf, Germany

PA-600
Stakeholders’ positioning in the uptake of new health care interventions: the case of the “Sustainable Access and Delivery of New Vaccines in Ghana” (SAVING) consortium 
Margaret Gyapong, University of Health and Allied Sciences, Ghana

PA-616
The effectiveness of providing alcohol based handrub to mothers for the prevention of severe illness and death in Ugandan infants: a community cluster randomised trial 
Martin Chebet, Busitema University, Uganda

PA-625
Nutritional status and malaria infection of pregnant women seen in antenatal care in San, Mali 
Mohamed Bougoury Traoré, Malaria Research and Training Center/université des sciences techniques et technologies de Bamako, Mali

PA-641
Developing a novel electronic communication system for ambulances in Rwanda: Contextualising the system locally 
Jean Claude Byiringiro, College of Medicine and Health Sciences, University of Rwanda, Rwanda

PA-647
Metagenomic sequencing of mpox virus clade Ib lesions identifies possible bacterial and viral co-infections in hospitalized patients in eastern DRC
Bas Oude Munnink, Erasmus MC, Netherlands

PA-657
Research into phytotherapy against infectious diseases in Benin: what real contribution to the health system? 
Mahutin Natacha Anne Michelle Aivodji, Animal Physiology Department at the University of Abomey-Calavi's Faculty of Sciences and Technologies, Benin

PA-672
Early initiation of breastfeeding and feeds after birth in Eastern Ugandan villages – findings from the BabyGel Trial 
Thorkild Tylleskar, University of Bergen, Norway

PA-677
Antibacterial Activities of Lactic Acid Bacteria Isolated from Bambara nut against Agents of Enteric and Respiratory Tract Infections 
Thomas Senghore, University of The Gambia, The Gambia

PA-678
High prevalence of HIV-sexually transmitted co-infections among adolescent girls and young women seeking hiv testing services in Uganda
Benjamin Watyaba, Uganda Virus Research Institute, Eastern Africa Consortium for Clinical Research, Uganda

PA-685
Reconstructing historical patterns of mosquito-borne viral infections in Cameroon using serological data 
Ngu Abanda, Centre Pasteur du Cameroun, Cameroon

PA-705
Assessing Phenotypic Susceptibility of Field Isolates from Three Distinct Sites in Mali using Old to Current and Lead Advanced Candidate Antimalarial Drugs
Fatoumata Ousmane Maiga, University of Sciences, Techniques and Technologies of Bamako, Mali

PA-717
Strengthening data quality during the transition to the who three-test HIV diagnosis algorithm: lessons from the littoral Region, Cameroon
Cyprien Kengne Nde, National Aids Control Committee, Cameroon

PA-718
Investigating the role of host immune responses in Plasmodium falciparum gametocytes carriage 
Hamtandi Magloire Natama, Institut de Recherche en Sciences de la Santé- Unité de Recherche Clinique de Nanoro, Burkina Faso

PA-723
Prevalence of dyslipidemia and its predictors among HIV positive pregnant and breastfeeding women on dolutegravir-based regimens in Ethiopia
Siraj Hussen Adem, Hawssa University, Ethiopia

PA-737
The progress of mother-to-child transmission of Human Immunodeficiency Virus (HIV) after Dolutegravir (DTG) optimization program: evidence from a multicenter cohort study in Ethiopia 
Abel Gedefaw Ali, Hawassa University, Ethiopia

PA-749
Evolution of malaria antigen-specific immune responses and antibody-dependent respiratory burst activity in longitudinal controlled human malaria infection model 
Nouhoun Barry, GRAS, Burkina Faso

PA-752
Evidence of dengue virus circulation among samples of febrile children screened for malaria at the sentinel malaria surveillance site in Libreville, Gabon: preliminary data 
Bridy Chesly Moutombi Ditombi, Université des Sciences de la Santé, Gabon

PA-755
Mentorship and innovation: a makeshift crèche to empower early-career women in academia at the biosciences faculty, Nnamdi Azikiwe University, Nigeria
Ogechukwu Aribodor, Nnamdi Azikiwe University, Nigeria

PA-778
Community Engagement in Health Research: Best Practices from HPV Vaccine Uptake Interventions in Africa
Okhesomi Eshemokhai, Health Equity Accelerator Leadership (HEAL) Society of Slums and Rural Health Initiative (SRHIN), Nigeria

PA-782
Evaluating the impact of computer-aided X-ray diagnosis to optimise Xpert-orientated community-based active case-finding for TB (XACT-19)
Alex Scott, University of Cape Town Lung Institute, South Africa

PA-787
Intermittent preventive treatment for malaria as a useful tool for reducing malaria-related morbidities in school-aged children: Tanzania’s experience from clinical trial, implementation, policy and practice
Geofrey Makenga, National Institute for Medical Research (NIMR), Tanzania

PA-790
Drivers of Delayed Care-Seeking Among Children Aged 6-35 Months with Medically Attended Diarrhea: Findings from the Enterics for Global Health (EFGH)-Shigella Study
Maureen Ndalama, Malawi Liverpool Wellcome Research Programme, Malawi

PA-810
Reducing HIV risk in Ogun, Nigeria: a cross-sectional study on the knowledge, preference and willingness to pay for different PrEP options among female sex workers
Jennifer Chinaecherem Onyehalu, Person-Centred HIV Research Team, Department of Clinical Pharmacy and Pharmacy Management, University of Nigeria, Nigeria

PA-841
Point-of-care molecular diagnostics for Community-Based Active Case-Finding: A Multicentre Randomised Controlled Trial on TB Detection and Treatment Initiation
Ashley Chizema, Biomedical Research and Training Institute, Zimbabwe

PA-844
Studying heterologous-induced immunity to tropical infectious diseases: a means to understand vaccine-induced immune memory in a sub-Saharan African population
Edlom Pélagie Tchadie, Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon

PA-845
Assessing the innate immune memory response in people living in high malaria transmission settings: insights from a pilot study in Gabon
Amana Bokagne Therese Vanessa, Centre de Recherches Medicales de Lambarene, Gabon